Erhalte eine Antwort von diesem Arbeitgeber
Dein Lebenslauf und dein Anschreiben, genau auf das zugeschnitten, was gesucht wird.
Sarah Cannon Research Institute (SCRI), a McKesson subsidiary, seeks a Director of Research Site Partnerships to lead executive relationships with oncology research sites and drive enrollment growth.
You will manage a portfolio of approximately 5–6 oncology sites, build partnerships with site leadership, physicians, and research teams, and align site strategy with enterprise priorities to accelerate trials.
It’s More Than a Career, It’s a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community‑based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission‑driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day. Our Mission People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting‑edge research, SCRI is redefining cancer care around the world. As the Director of Research Site Partnerships you serve as the executive relationship owner for a portfolio of oncology research sites. You will drive site engagement, alignment, and performance through strategic partnership and a focus on clinical trial enrollment growth. You will operate as a strategic account leader, navigating complex situations, influencing outcomes, and partnering across leadership to align priorities, remove barriers, and deliver value in a matrixed environment.
About SarahCannon Research Institute Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community‑based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first‑in‑human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings. We care about the well‑being of the patients and communities we serve, and that starts with caring for our people.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status. McKesson is an impact-driven, Fortune 10 company that touches virtually every aspect of healthcare. We are known for delivering insights, products, and services that make quality care more accessible and affordable. Here, we focus on the health, happiness, and well‑being of you and those we serve – we care. What you do at McKesson matters. We foster a culture where you can grow, make an impact, and are empowered to bring new ideas. Together, we thrive as we shape the future of health for patients, our communities, and our people. If you want to be part of tomorrow’s health today, we want to hear from you.